Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000525044 | SCV000659381 | likely benign | Adams-Oliver syndrome 5 | 2022-08-13 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002413651 | SCV002721923 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2020-12-02 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
CHEO Genetics Diagnostic Laboratory, |
RCV002413651 | SCV004239525 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2022-10-19 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV001579995 | SCV001809297 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV001579995 | SCV001954613 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001579995 | SCV001969625 | likely benign | not provided | no assertion criteria provided | clinical testing |